Strathprints logo
Strathprints Home | Open Access | Browse | Search | User area | Copyright | Help | Library Home | SUPrimo

Differential effects of 17ß-oestradiol on stroke damage in stroke prone (SHRSP) and normotensive rats

Carswell, H.V.O. and Bingham, D. and Wallace, K. and Nilsen, M. and Graham, D.I. and Dominiczak, A.F. and Macrae, I.M. (2004) Differential effects of 17ß-oestradiol on stroke damage in stroke prone (SHRSP) and normotensive rats. Journal of Cerebral Blood Flow and Metabolism, 24 (3). pp. 298-304. ISSN 0271-678X

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

We previously reported that during pro-estrus (high endogenous estrogen levels), brain damage after middle cerebral artery occlusion (MCAO) was reduced in stroke-prone spontaneously hypertensive rats (SHRSP) but not in normotensive Wistar Kyoto rat (WKY). In the present study, we examined the effect of exogenous estrogen on brain damage after MCAO in SHRSP and WKY. A 17-estradiol (0.025mg or 0.25mg, 21 day release) or matching placebo pellet was implanted into ovariectomized WKY and SHRSP (3 to 4 months old) who then underwent distal diathermy-induced MCAO 2 weeks later. Plasma 17-estradiol levels for placebo and 17-estradiol groups were as follows: WKY 0.025 mg 16.4 8.5 (pg/mL, mean SD) and 25.85 12.6; WKY 0.25 mg 18.2 9.0 and 69.8 27.4; SHRSP 0.25 mg 20.7 8.8 and 81.0 16.9. In SHRSP, infarct volumes at 24 hours after MCAO were similar in placebo and 17-estradiol groups: SHRSP 0.025 mg 126.7 15.3 mm3 (n = 6) and 114.0 14.1 mm3 (n = 8) (not significant); SHRSP 0.25 mg 113.5 22.3 mm3 (n = 8) and 129.7 26.2 mm3 (n = 7) (not significant), respectively. In WKY, 17-estradiol significantly increased infarct volume by 65% with 0.025mg dose [36.1 20.7 mm3 (n = 8) and 59.7 19.3 mm3 (n = 8) (P = 0.033, unpaired t-test)] and by 96% with 0.25 mg dose [55.9 36.4 mm3 (n = 8) and 109.7 6.7 mm3 (n = 4) (P = 0.017)]. Thus, 17-estradiol increased stroke damage in normotensive rats with no significant effect in stroke-prone rats. Despite being contrary to our hypothesis, our findings add substance to the recently reported negative effects of 17-estradiol in clinical studies.

Item type: Article
ID code: 37890
Keywords: estrogen , SHRSP , middle cerebral artery occlusion, brain damage, Pharmacy and materia medica, Clinical Neurology, Cardiology and Cardiovascular Medicine, Neurology
Subjects: Medicine > Pharmacy and materia medica
Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Faculty of Humanities and Social Sciences (HaSS) > School of Psychological Science and Health > Counselling
Related URLs:
    Depositing user: Pure Administrator
    Date Deposited: 24 Feb 2012 16:56
    Last modified: 04 Sep 2014 19:28
    URI: http://strathprints.strath.ac.uk/id/eprint/37890

    Actions (login required)

    View Item